Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Rozenblit who wrote (2913)	2/4/1999 1:20:00 PM
From: stock bull	Respond to of 3725

Bruce, re:<<As far as cardiologists are concerned, I am convinced that there are 2 camps, those for and those against. The only logical reason I can come with why they would fight the technology is that they fear it will reduce fee base by replacing more lucrative traditional procedures.>> This is a double edged sword. First, the Scanner would end up referring more people to cardiologists for follow-up exams. Don't forget, if the Scanner shows calcium in the persons arteries, the person quickly becomes a cardiac patient. Second, I suspect the Scanner will cut into the number of angiograms given. In fact, if the Scanner, with the capability to perform a "fly through" exam proves to be as accurate as the angiogram, well the new "gold standard" would become the Scanner. As I said before, its hard for a hospital, or heart check center, to spend two million dollars for a Scanner and than charge 400 to 500 dollars per scan. It would take 4000 scans to brake even! (Very simple analysis...overlooks overhead, staffing, etc.) Stock Bull